Literature DB >> 1517154

A novel type of phospholipase A2 inhibitor, thielocin A1 beta, and mechanism of action.

K Tanaka1, S Matsutani, K Matsumoto, T Yoshida.   

Abstract

Thielocin A1 beta, a novel phospholipase A2 inhibitor, was isolated from Thielavia terricola RF-143. It inhibited various phospholipase A2s in a dose-dependent manner. Among these, group II phospholipase A2 from rat was most sensitive to thielocin A1 beta (IC50 = 0.0033 microM). The inhibition of phospholipase A2 by thielocin A1 beta was independent of Ca2+ and substrate concentration. In addition, the inhibition of rat group II phospholipase A2 was noncompetitive (Ki = 0.0068 microM) and reversible. Furthermore, thielocin A1 beta quenched the relative fluorescent intensity of Naja naja venom phospholipase A2 and in a dose-dependent manner; 50% quench was noted with a molar ratio of thielocin A1 beta/enzyme of 2.2. These observations indicated that inhibition of phospholipase A2 by thielocin A1 beta may result from direct interaction with the enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1517154     DOI: 10.7164/antibiotics.45.1071

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Increased activity of group II phospholipase A2 in plasma in rat sodium deoxycholate induced acute pancreatitis.

Authors:  S Furue; Y Hori; K Kuwabara; J Ikeuchi; H Onoyama; M Yamamoto; K Tanaka
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

2.  Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion.

Authors:  A Matsuzawa; M Murakami; G Atsumi; K Imai; P Prados; K Inoue; I Kudo
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

3.  Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy.

Authors:  K Tanaka; T Kato; K Matsumoto; T Yoshida
Journal:  Inflammation       Date:  1993-04       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.